FinTech Collective

FinTech Collective is a venture capital firm, based in New York City and investing globally. Our ambition is to create the future of financial services, bringing transparency and choice to developed markets and financial connectivity and socio-economic mobility to developing markets. The firm was founded in 2012 by serial entrepreneurs with exits in capital markets, payments and enterprise AI. Since inception, FinTech Collective has invested in over 50 companies including Anyfin (Stockholm), Axoni (NYC), Flutterwave (Africa), IMMO Capital (London), Minu (Latin America), MoneyLion (NYC), NYDIG (NYC), Ocrolus (NYC), Vestwell (NYC) and Willa (Stockholm / LA). Exits include Quovo (acquired by Plaid), Openfolio (acquired by Stone Ridge Asset Management), Reorg (acquired by Warburg Pincus), Slide (acquired by Raise), Artivest (acquired by iCapital) and TradeBlock (acquired by CoinDesk). The firm is currently investing out of its third fund, a $200m early-stage fund with a focus on capital markets, wealth and asset management, banking-lending-payments, and insurance. The firm actively invests in decentralized finance ("defi") opportunities across these segments. We publish a weekly newsletter, delivered every Saturday and providing a tightly edited rundown of global fintech news, along with a bit of our original analysis (available at fintech.io/newsletter).

MATTERS2

At Matters2 we desire to change the world for the Better. But, like most things, the change we desire won't come about by itself. Rome wasn't built in a day nor accomplished by a select few. It was built on universally accepted ideals and inspired one and all to facilitate and maintain the change that was needed. We wish to be the catalyst for change not only in our industry but in our communities as well. We promote the ideals of integrity, transparency and enriching those around us. We believe in giving first. At Matters2 we desire to see this change materialise. Much the same as the people and businesses that we seek to assist. We need motivated people who long for the betterment of humankind, agents of change, and dreamers that shoot for the stars. We need Founders. Founders like you. And we are here to help you bring about that change and disrupt the status quo. We are an independent consultancy boutique focused on assisting early-stage ventures in navigating the fundraising process and connecting to investors through providing the following services: Fundraising Pre-money Valuation Pitch Deck Creation Info-Memo Development EIS pre-approval Sell-Side Due Diligence Crowdfunding Setup Fundraising Journey Fractional Management Corporate Structuring Unlike traditional advisors, we are accessible, down to earth and we go beyond our scope, helping our clients assess every aspect of their business and helping to structure the company before reaching out to investors. In short, we assist the dreamers and agents of change in bringing their dreams to life by building a human to human relationships and walking with them along the journey to success.

BC Capital Partners Ltd

Founded in 2016 by Christian Barozzi and Andrej Carpani, BC Capital is an independent and international advisory firm providing strategic and legal advisory services for the Asset Management industry and advisory services for Corporate clients. Thanks to the experience and competences of its partners BC Capital offers a tailor made advisory service to asset managers and corporate clients. We assist our clients and we support them in identifying the best solutions. We're an independent boutique and thanks to our experience, the entrepreneurial spirit of the partners and our network, we can help clients in their growth path.

VentureFounders

VentureFounders is one of the UK's leading investors in FinTech and SaaS scale-up businesses from Series A and beyond. We are a collective of entrepreneurs, operators and financial services experts who turned our passion in technology into investing in some of the UK's leading tech success stories. We've been investing since 2014 and our portfolio is now over 35 strong. We back ambitious founders and CEOs who, we believe, have the potential to become global leaders in their industries. We are committed to supporting them at every stage of their journey, helping them to realise their full potential. The way our capital is structured means that we aren't constrained by traditional fund dynamics and we are true patient capital, having the ability to invest for the long term. If you are interested in joining our community or are a business seeking investment, please get in touch with us at info@venturefounders.co.uk _______________________ VentureFounders Limited is authorised and regulated by the Financial Conduct Authority (FRN: 613003) © Venture Founders Limited 2013-2018. All rights reserved. Venture Founders is a limited company registered in England and Wales (No. 8636143). Registered address: Venture Founders Ltd, 46-54 High Street, Ingatestone, England, CM4 9DW RISK WARNING: Investing in startups and early stage businesses involves risks, including illiquidity, lack of dividends, loss of your investment and dilution and it should be done only as part of a diversified portfolio. VentureFounders is targeted exclusively at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. Investment opportunities are not offers to the public and you will only be able to invest with VentureFounders once you have made the appropriate declarations and been accepted as a VentureFounders member. Read the full risk warnings at www.venturefounders.co.uk/risk Read the full risk warnings at www.venturefounders.co.uk/risk

Abingworth

Abingworth is a leading transatlantic life sciences investment firm. Abingworth helps transform cutting-edge science into novel medicines by providing capital and expertise to top caliber management teams building world-class companies. Since 1973, Abingworth has invested in over 175 life science companies, leading to 46 M&As and 70+ IPOs. Our therapeutic focused investments fall into three categories: seed and early-stage, development stage, and clinical co-development. Abingworth supports its portfolio companies with a team of experienced professionals at offices in London, Menlo Park (California), and Boston. Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022.